of real-time technology for precise tracking, and Siemens Healthcare. Following this agreement, the capability of detecting and tracking tumor cells during radiation therapy treatments is expected to be markedly improved. According to this three-year period agreement, Siemens will have non-exclusive rights to deploy and sell Calypso’s real-time tracking technology to the current and potential Siemens' progressively increasing customers throughout Europe.
Monday, 6 September 2010
Siemens Sells Calypso’s Tracking Technology Of Tumor Cells.
A new product distribution agreement has been signed between Calypso Medical Technologies, Inc., a developer of real-time technology for precise tracking, and Siemens Healthcare. Following this agreement, the capability of detecting and tracking tumor cells during radiation therapy treatments is expected to be markedly improved. According to this three-year period agreement, Siemens will have non-exclusive rights to deploy and sell Calypso’s real-time tracking technology to the current and potential Siemens' progressively increasing customers throughout Europe.
of real-time technology for precise tracking, and Siemens Healthcare. Following this agreement, the capability of detecting and tracking tumor cells during radiation therapy treatments is expected to be markedly improved. According to this three-year period agreement, Siemens will have non-exclusive rights to deploy and sell Calypso’s real-time tracking technology to the current and potential Siemens' progressively increasing customers throughout Europe.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment